S100 proteins in IgA vasculitis and other systemic vasculitides – from pathogenic mechanisms to clinical biomarkers: a systematic review

Key Takeaways for GI Nurses

• S100 proteins may serve as valuable biomarkers for detecting and monitoring IgA vasculitis and other systemic vasculitides that can affect the gastrointestinal tract
• Understanding S100 protein involvement in vasculitic conditions helps nurses better recognize potential systemic complications in patients presenting with GI symptoms
• This research supports the development of more targeted diagnostic approaches that could improve early identification of vasculitis in patients undergoing endoscopic evaluation
• Enhanced biomarker knowledge enables more informed patient education and better coordination with rheumatology and immunology specialists when vasculitis is suspected

Clinical Relevance

IgA vasculitis, formerly known as Henoch-Schönlein purpura, frequently presents with gastrointestinal manifestations including abdominal pain, gastrointestinal bleeding, and bowel wall inflammation that may be encountered during endoscopic procedures. As GI nurses, recognizing the potential for systemic vasculitis in patients presenting with these symptoms is crucial for appropriate care coordination and patient safety. The identification of S100 proteins as potential biomarkers represents a significant advancement in our ability to diagnose and monitor these complex conditions that bridge gastroenterology and rheumatology.

The clinical implications extend beyond diagnosis to patient monitoring and care planning. Patients with suspected or confirmed vasculitis requiring endoscopic evaluation may present unique challenges, including increased bleeding risk, medication interactions with immunosuppressive therapy, and the need for enhanced post-procedure monitoring. Understanding the role of S100 proteins in disease pathogenesis and monitoring helps nurses anticipate complications and collaborate more effectively with the interdisciplinary team. This knowledge also supports more comprehensive patient assessment, particularly in identifying subtle signs of systemic involvement that might otherwise be overlooked during routine GI care.

From a unit operations perspective, this research highlights the importance of maintaining strong communication pathways with rheumatology and immunology services. Nurses working in endoscopy units should be prepared to facilitate rapid consultation and coordinate care for patients with suspected vasculitis. Additionally, understanding biomarker research like this supports evidence-based practice initiatives and helps nurses stay current with evolving diagnostic approaches that may impact patient preparation, procedure protocols, and post-procedure care plans.

Bottom Line

This systematic review on S100 proteins in vasculitis reinforces the critical role that GI and endoscopy nurses play in recognizing systemic conditions presenting with gastrointestinal symptoms. While S100 proteins represent promising biomarkers for vasculitis diagnosis and monitoring, the immediate impact for nurses lies in understanding that patients with GI manifestations may have underlying systemic vasculitis requiring specialized care coordination, enhanced monitoring, and interdisciplinary collaboration to ensure optimal outcomes and patient safety during endoscopic procedures.